Kansas City

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• CIDP (chronic inflammatory demyelinating polyneuropathy)1 trial
• Lung cancer1 trial
• Myasthenia gravis1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Recruiting2 trials
• Active, not recruiting1 trial

Lead sponsor

• Dianthus Therapeutics2 trials
• Summit Therapeutics1 trial

Running trials

• Recruiting

  Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

  NCT06767514· Phase 3· Summit Therapeutics· Source

• Recruiting

  A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

  NCT06858579· Phase 3· Dianthus Therapeutics· Source

• Active, not recruiting

  A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC)

  NCT06282159· Phase 2· Dianthus Therapeutics· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
• Lung cancer1 recruiting